|
|
||||||||
The Journal of Immunology, Vol 158, Issue 12 5676-5684, Copyright © 1997 by American Association of Immunologists
ARTICLES |
L Lu, S Qian, PA Hershberger, WA Rudert, DH Lynch and AW Thomson
Thomas E. Starzl Transplantation Institute and the Department of Surgery, University of Pittsburgh, PA 15213, USA.
Activation of T cells is induced efficiently by dendritic cells (DC), but little is known about the role of DC in the regulation of T cell death. In this study, highly purified DC (DEC-205+, MHC class II(high), B7-1+ [CD80+], B7-2high [CD86high], CD40+, CD11c+) grown from normal mouse bone marrow in granulocyte-macrophage CSF + IL-4 were found to express FasL (CD95L) mRNA by reverse transcriptase PCR and to uniformly express FasL by both flow cytometric and immunocytochemical analyses. These cells, but not DC propagated from FasL-deficient (B6.gld) mice, induced dose-dependent increases in DNA fragmentation in Fas+ Jurkat T cells over 18 h coculture. Addition of mouse Fas-Fc fusion protein at the start of the cultures diminished this effect. Even at high relative concentrations, however, B7-2high DC induced only low levels of DNA fragmentation in Con A or alloactivated splenic T cells, as determined by radio- or spectrofluorometric assays and by in situ nick-end labeling. However, in the presence of CTLA4Ig, a molecule that blocks the B7-CD28 costimulatory pathway, DC that failed to stimulate in primary MLR induced markedly augmented levels of apoptosis in alloactivated T cells. CTLA4Ig treatment also increased the level of DNA fragmentation induced by FasL-deficient DC, indicating the existence of additional potential (Fas-independent) pathways of DC- induced T cell death. These findings suggest that the costimulatory (B7- CD28) and T cell death-inducing pathways may play important counter- regulatory roles in dictating the outcome of (allogeneic) DC-T cell interactions.
This article has been cited by other articles:
![]() |
C. Chauvin and R. Josien Dendritic Cells as Killers: Mechanistic Aspects and Potential Roles J. Immunol., July 1, 2008; 181(1): 11 - 16. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Papewalis, B. Jacobs, M. Wuttke, E. Ullrich, T. Baehring, R. Fenk, H. S. Willenberg, S. Schinner, M. Cohnen, J. Seissler, et al. IFN-{alpha} Skews Monocytes into CD56+-Expressing Dendritic Cells with Potent Functional Activities In Vitro and In Vivo J. Immunol., February 1, 2008; 180(3): 1462 - 1470. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Guo, D. Weih, E. Meier, and F. Weih Constitutive alternative NF-{kappa}B signaling promotes marginal zone B-cell development but disrupts the marginal sinus and induces HEV-like structures in the spleen Blood, October 1, 2007; 110(7): 2381 - 2389. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Harnaha, J. Machen, M. Wright, R. Lakomy, A. Styche, M. Trucco, S. Makaroun, and N. Giannoukakis Interleukin-7 Is a Survival Factor for CD4+ CD25+ T-Cells and Is Expressed by Diabetes-Suppressive Dendritic Cells Diabetes, January 1, 2006; 55(1): 158 - 170. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Huang, T. Tatsumi, E. Pizzoferrato, N. Vujanovic, and W. J. Storkus Nitric Oxide Sensitizes Tumor Cells to Dendritic Cell-Mediated Apoptosis, Uptake, and Cross-Presentation Cancer Res., September 15, 2005; 65(18): 8461 - 8470. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Machen, J. Harnaha, R. Lakomy, A. Styche, M. Trucco, and N. Giannoukakis Antisense Oligonucleotides Down-Regulating Costimulation Confer Diabetes-Preventive Properties to Nonobese Diabetic Mouse Dendritic Cells J. Immunol., October 1, 2004; 173(7): 4331 - 4341. [Abstract] [Full Text] [PDF] |
||||
![]() |
R Okazaki, A Sakai, A Ootsuyama, T Sakata, T Nakamura, and T Norimura Trabecular bone mass and bone formation are preserved after limb immobilisation in p53 null mice Ann Rheum Dis, April 1, 2004; 63(4): 453 - 456. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Colino and C. M. Snapper Two Distinct Mechanisms For Induction of Dendritic Cell Apoptosis in Response to Intact Streptococcus pneumoniae J. Immunol., September 1, 2003; 171(5): 2354 - 2365. [Abstract] [Full Text] [PDF] |
||||
![]() |
A H Lau, A de Creus, L Lu, and A W Thomson Liver tolerance mediated by antigen presenting cells: fact or fiction? Gut, August 1, 2003; 52(8): 1075 - 1078. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Ma, S. Qian, X. Liang, L. Wang, J. E. Woodward, N. Giannoukakis, P. D. Robbins, S. Bertera, M. Trucco, J. J. Fung, et al. Prevention of Diabetes in NOD Mice by Administration of Dendritic Cells Deficient in Nuclear Transcription Factor-{kappa}B Activity Diabetes, August 1, 2003; 52(8): 1976 - 1985. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Elhalel, J.-H. Huang, W. Schmidt, J. Rachmilewitz, and M. L. Tykocinski CTLA-4 {middle dot} FasL Induces Alloantigen-Specific Hyporesponsiveness J. Immunol., June 15, 2003; 170(12): 5842 - 5850. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Maksimow, M. Santanen, S. Jalkanen, and A. Hanninen Responding naive T cells differ in their sensitivity to Fas engagement: early death of many T cells is compensated by costimulation of surviving T cells Blood, May 15, 2003; 101(10): 4022 - 4028. [Abstract] [Full Text] [PDF] |
||||
![]() |
A H Lau and A W Thomson Dendritic cells and immune regulation in the liver Gut, February 1, 2003; 52(2): 307 - 314. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Bonham, L. Peng, X. Liang, Z. Chen, L. Wang, L. Ma, H. Hackstein, P. D. Robbins, A. W. Thomson, J. J. Fung, et al. Marked Prolongation of Cardiac Allograft Survival by Dendritic Cells Genetically Engineered with NF-{kappa}B Oligodeoxyribonucleotide Decoys and Adenoviral Vectors Encoding CTLA4-Ig J. Immunol., September 15, 2002; 169(6): 3382 - 3391. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Lu, B. M. Janjic, J. Janjic, T. L. Whiteside, W. J. Storkus, and N. L. Vujanovic Innate Direct Anticancer Effector Function of Human Immature Dendritic Cells. II. Role of TNF, Lymphotoxin-{alpha}1{beta}2, Fas Ligand, and TNF-Related Apoptosis-Inducing Ligand J. Immunol., February 15, 2002; 168(4): 1831 - 1839. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Lipscomb and B. J. Masten Dendritic Cells: Immune Regulators in Health and Disease Physiol Rev, January 1, 2002; 82(1): 97 - 130. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. O'Connell, W. Li, Z. Wang, S. M. Specht, A. J. Logar, and A. W. Thomson Immature and Mature CD8{alpha}+ Dendritic Cells Prolong the Survival of Vascularized Heart Allografts J. Immunol., January 1, 2002; 168(1): 143 - 154. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wei, K. Chen, G. C. Sharp, H. Yagita, and H. Braley-Mullen Expression and Regulation of Fas and Fas Ligand on Thyrocytes and Infiltrating Cells During Induction and Resolution of Granulomatous Experimental Autoimmune Thyroiditis J. Immunol., December 1, 2001; 167(11): 6678 - 6686. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Jodo, S. Xiao, A. Hohlbaum, D. Strehlow, A. Marshak-Rothstein, and S.-T. Ju Apoptosis-inducing Membrane Vesicles. A NOVEL AGENT WITH UNIQUE PROPERTIES J. Biol. Chem., October 19, 2001; 276(43): 39938 - 39944. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Vanderheyde, E. Aksoy, Z. Amraoui, P. Vandenabeele, M. Goldman, and F. Willems Tumoricidal Activity of Monocyte-Derived Dendritic Cells: Evidence for a Caspase-8-Dependent, Fas-Associated Death Domain-Independent Mechanism J. Immunol., October 1, 2001; 167(7): 3565 - 3569. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-O. Vidalain, O. Azocar, H. Yagita, C. Rabourdin-Combe, and C. Servet-Delprat Cytotoxic Activity of Human Dendritic Cells Is Differentially Regulated by Double-Stranded RNA and CD40 Ligand J. Immunol., October 1, 2001; 167(7): 3765 - 3772. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Lu, A. Achour, M. Arlie, L. Cao, and J.-M. Andrieu Enhanced Dendritic Cell-Driven Proliferation and Anti-HIV Activity of CD8+ T Cells by a New Phenothiazine Derivative, Aminoperazine J. Immunol., September 1, 2001; 167(5): 2929 - 2935. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kiba, S. Saito, K. Numata, Y. Kon, T. Mizutani, and H. Sekihara Expression of apoptosis on rat liver by hepatic vagus hyperactivity after ventromedial hypothalamic lesioning Am J Physiol Gastrointest Liver Physiol, May 1, 2001; 280(5): G958 - G967. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Li, L. Lu, Z. Wang, L. Wang, J. J. Fung, A. W. Thomson, and S. Qian IL-12 Antagonism Enhances Apoptotic Death of T Cells Within Hepatic Allografts from Flt3 Ligand-Treated Donors and Promotes Graft Acceptance J. Immunol., May 1, 2001; 166(9): 5619 - 5628. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-H. Huang and M. L. Tykocinski CTLA-4-Fas ligand functions as a trans signal converter protein in bridging antigen-presenting cells and T cells Int. Immunol., April 1, 2001; 13(4): 529 - 539. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.M. Pinedo, T.D. de Gruijl, E. van der Wall, and J. Buter Biological Concepts of Prolonged Neoadjuvant Treatment plus GM-CSF in Locally Advanced Tumors Oncologist, December 1, 2000; 5(6): 497 - 500. [Abstract] [Full Text] |
||||
![]() |
J. O. Funk, H. Walczak, C. Voigtlander, S. Berchtold, T. Baumeister, P. Rauch, S. Rossner, A. Steinkasserer, G. Schuler, and M. B. Lutz Cutting Edge: Resistance to Apoptosis and Continuous Proliferation of Dendritic Cells Deficient for TNF Receptor-1 J. Immunol., November 1, 2000; 165(9): 4792 - 4796. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Trinite, C. Voisine, H. Yagita, and R. Josien A Subset of Cytolytic Dendritic Cells in Rat J. Immunol., October 15, 2000; 165(8): 4202 - 4208. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Morelli, M. A. Antonysamy, T. Takayama, H. Hackstein, Z. Chen, S. Qian, N. B. Zurowski, and A. W. Thomson Microchimerism, Donor Dendritic Cells, and Alloimmune Reactivity in Recipients of Flt3 Ligand-Mobilized Hemopoietic Cells: Modulation by Tacrolimus J. Immunol., July 1, 2000; 165(1): 226 - 237. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. T. LEONARD, P. M. SOCCAL, L. SINGER, G. J. BERRY, J. THEODORE, P. G. HOLT, R. L. DOYLE, and G. D. ROSEN Dendritic Cells and Macrophages in Lung Allografts . A Role in Chronic Rejection? Am. J. Respir. Crit. Care Med., April 1, 2000; 161(4): 1349 - 1354. [Abstract] [Full Text] |
||||
![]() |
A. I. Chapoval, K. Tamada, and L. Chen In vitro growth inhibition of a broad spectrum of tumor cell lines by activated human dendritic cells Blood, April 1, 2000; 95(7): 2346 - 2351. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-P. Min, R. Gorczynski, X.-Y. Huang, M. Kushida, P. Kim, M. Obataki, J. Lei, R. M. Suri, and M. S. Cattral Dendritic Cells Genetically Engineered to Express Fas Ligand Induce Donor-Specific Hyporesponsiveness and Prolong Allograft Survival J. Immunol., January 1, 2000; 164(1): 161 - 167. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. Fanger, C. R. Maliszewski, K. Schooley, and T. S. Griffith Human Dendritic Cells Mediate Cellular Apoptosis via Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) J. Exp. Med., October 18, 1999; 190(8): 1155 - 1164. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Matsue, D. Edelbaum, A. C. Hartmann, A. Morita, P. R. Bergstresser, H. Yagita, K. Okumura, and A. Takashima Dendritic Cells Undergo Rapid Apoptosis In Vitro During Antigen-Specific Interaction with CD4+ T Cells J. Immunol., May 1, 1999; 162(9): 5287 - 5298. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kanto, N. Hayashi, T. Takehara, T. Tatsumi, N. Kuzushita, A. Ito, Y. Sasaki, A. Kasahara, and M. Hori Impaired Allostimulatory Capacity of Peripheral Blood Dendritic Cells Recovered from Hepatitis C Virus-Infected Individuals J. Immunol., May 1, 1999; 162(9): 5584 - 5591. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-g. Zhang, X. Su, D. Liu, W. Liu, P. Yang, Z. Wang, C. K. Edwards, H. Bluethmann, J. D. Mountz, and T. Zhou Induction of Specific T Cell Tolerance by Fas Ligand- Expressing Antigen-Presenting Cells J. Immunol., February 1, 1999; 162(3): 1423 - 1430. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. ROSSINI, D. L. GREINER, and J. P. MORDES Induction of Immunologic Tolerance for Transplantation Physiol Rev, January 1, 1999; 79(1): 99 - 141. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Dai, B. T. Konieczny, F. K. Baddoura, and F. G. Lakkis Impaired Alloantigen-Mediated T Cell Apoptosis and Failure To Induce Long-Term Allograft Survival in IL-2-Deficient Mice J. Immunol., August 15, 1998; 161(4): 1659 - 1663. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Gardby, P. Lane, and N. Y. Lycke Requirements for B7-CD28 Costimulation in Mucosal IgA Responses: Paradoxes Observed in CTLA4-H{gamma}1 Transgenic Mice J. Immunol., July 1, 1998; 161(1): 49 - 59. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Antonysamy, R. J. Steptoe, A. Khanna, W. A. Rudert, V. M. Subbotin, and A. W. Thomson Flt-3 Ligand Increases Microchimerism But Can Prevent the Therapeutic Effect of Donor Bone Marrow in Transiently Immunosuppressed Cardiac Allograft Recipients J. Immunol., April 15, 1998; 160(8): 4106 - 4113. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. McLeod, L. S. K. Walker, Y. I. Patel, G. Boulougouris, and D. M. Sansom Activation of Human T Cells with Superantigen (Staphylococcal Enterotoxin B) and CD28 Confers Resistance to Apoptosis via CD95 J. Immunol., March 1, 1998; 160(5): 2072 - 2079. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Shortman and C. Caux Dendritic Cell Development: Multiple Pathways to Nature's Adjuvants Stem Cells, November 1, 1997; 15(6): 409 - 419. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |